Galaxy Medicare Share Price Today | Stock Price & Galaxy Medicare Share Screener
Track the current Galaxy Medicare share price and stock price live with TickJournal's free stock screener. Check GML 52-week performance for the annual price range and momentum. Use the Galaxy Medicare stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Galaxy Medicare opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Key Statistics and Valuation Ratios
Galaxy Medicare Share Price Chart
Track the current stock price of Galaxy Medicare with an interactive chart. Analyse GML share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Galaxy Medicare stock quote in one place.
Galaxy Medicare Company Profile - Fundamental Screener
Screen Galaxy Medicare company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for GML shares across the equity market and its stock price history, plus the wider market trend.
The company is classified under the Healthcare sector and the Medical Equipment industry, and it trades under ISIN INE09A801015.
Company Details
Classification
Identifiers and Leadership
Galaxy Medicare Balance Sheet Screener
Screen GML balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.
For 2026, total assets were ₹49, up from ₹32 in 2025.
Latest statistics put total assets at ₹49 and shareholder funds at ₹40, with a leverage ratio of 0.17.
| Item | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
Assets |
||||||
| Total Assets | 49 | 32 | 33 | 32 | 31 | 30 |
| Current Assets | 31 | 15 | 15 | 15 | 14 | 13 |
| Fixed Assets | 15 | 14 | 14 | 14 | 15 | 14 |
Liabilities |
||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 1 | 1 | 2 | 3 | 4 | 2 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 |
Shareholders' Equity |
||||||
| Total Equity | 40 | 24 | 21 | 18 | 16 | 16 |
| Share Capital | 15 | 12 | 12 | 3 | 3 | 3 |
| Reserves & Surplus | 25 | 12 | 10 | 15 | 13 | 13 |
Galaxy Medicare Income Statement Screener - Profit & Revenue Analysis
Screen Galaxy Medicare income statement and profit fundamentals. Analyze GML quarterly results. Galaxy Medicare reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.
For None-None, revenue was ₹0 and net profit was ₹0.
In that period expenses were ₹0, interest cost ₹0 and tax ₹0. The next period listed, 2026-March, shows revenue of ₹41 and net profit of ₹3.
| Item | None-None | 2026-March | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March |
|---|---|---|---|---|---|---|---|
Revenue and Expenses | |||||||
| Revenue | 0 | 41 | 40 | 37 | 32 | 31 | 29 |
| Expenses | 0 | 36 | 35 | 31 | 29 | 27 | 27 |
Operating Costs and Margins | |||||||
| EBITDA | 0 | 6 | 6 | 6 | 3 | 3 | 3 |
| Operating Profit % | 0.00% | 11.00% | 12.00% | 14.00% | 7.00% | 8.00% | 7.00% |
| Depreciation | 0 | 1 | 1 | 1 | 1 | 1 | 1 |
| Interest | 0 | 0 | 1 | 1 | 1 | 1 | 1 |
Profit and Earnings | |||||||
| Profit Before Tax | 0 | 5 | 5 | 5 | 2 | 0 | 1 |
| Tax | 0 | 1 | 1 | 1 | 0 | 0 | 0 |
| Net Profit | 0 | 3 | 3 | 4 | 2 | 0 | 1 |
| EPS | 0.00 | 2.50 | 2.84 | 3.13 | 5.17 | -0.70 | 2.56 |
Galaxy Medicare Cash Flow Screener - Liquidity Fundamentals
Screen GML cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.
In 2026-March, operating activities generated ₹2.
Over the same period, investing activities used ₹14 and financing activities provided ₹12.
| Item | 2026-March | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March |
|---|---|---|---|---|---|---|
Cash from Operations and Investing | ||||||
| Operating Activities | 2 | 5 | 3 | 4 | -1 | 6 |
| Investing Activities | -14 | 0 | -1 | -2 | -1 | -5 |
Financing and Net Cash | ||||||
| Financing Activities | 12 | -5 | -2 | -2 | 1 | -1 |
| Net Cash Flow | 0 | 0 | 0 | 0 | 0 | 0 |
Galaxy Medicare Shareholding Pattern Screener
See Galaxy Medicare shareholding pattern with promoter, FII, and DII holdings. Check Galaxy Medicare promoter holding and ownership changes for GML on TickJournal, and see how institutional stock price moves affect the market.
In 2026-Mar, promoters held 72.98%, foreign institutions 0.00%, domestic institutions 0.00% and the public 24.37%, spread across 867 shareholders.
The shareholder count was 867 in 2026-Mar, compared with 17 in 2025-Mar.
| Item | 2026-Mar | 2025-Mar | 2025-Sept |
|---|---|---|---|
Promoter Holding | |||
| Promoter Holding | 72.98% | 99.57% | 72.43% |
Institutional Investors | |||
| FII Holding | 0.00% | 0.00% | 0.00% |
| DII Holding | 0.00% | 0.00% | 0.00% |
Government, Public and Others | |||
| Govt Holding | 0.00% | 0.00% | 0.00% |
| Public Holding | 24.37% | 0.43% | 24.74% |
| Other Holding | 2.65% | 0.00% | 2.83% |
| Shareholder Count | 867 | 17 | 17 |
Dividend Yield Screener - Share Price & Share Analysis
Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Galaxy Medicare. Galaxy Medicare dividend yield can be compared with peers and other stocks in the market.
The latest dividend recorded was ₹0.70 per unit for 2026-March, a yield of 4.00%, compared with ₹0.00 for 2025-March.
Dividends are listed for 10 periods, with the three most recent payouts at ₹0.70, ₹0.00 and ₹0.00 per unit.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2026-March | ₹0.70 | 4.00% |
| 2025-March | ₹0.00 | 0.00% |
| 2024-March | ₹0.00 | 0.00% |
| 2023-March | ₹0.00 | 0.00% |
| 2022-March | ₹0.00 | 0.00% |
| 2021-March | ₹0.00 | 0.00% |
| 2020-March | ₹0.00 | 0.00% |
| 2019-March | ₹0.00 | 0.00% |
| 2018-March | ₹0.00 | 0.00% |
| 2017-March | ₹0.00 | 0.00% |
Galaxy Medicare Stock Index Membership - Nifty & Sensex
See which indices include Galaxy Medicare stock. Check GML index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.
Complete Index List
Galaxy Medicare Market Events Screener - Corporate Actions
Get Galaxy Medicare corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Galaxy Medicare stock events that may affect GML share price, along with derivatives, futures and options activity and sector gainers.
5 corporate actions are listed, the most recent entry being Dividend dated September 11, 2026, with a record date of September 11, 2026.
It is followed by Quarterly Result Announcement dated May 29, 2026 and Dividend dated December 17, 2025.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-09-11 | 2026-09-11 | Dividend | ₹ 0.35 /share | -16.20% |
| 2026-05-29 | 2026-05-29 | Quarterly Result Announcement | NA | 2.07% |
| 2025-12-17 | 2025-12-17 | Dividend | ₹ 0.35 /share | 14.10% |
| 2025-12-10 | 2025-12-10 | Quarterly Result Announcement | NA | 5.12% |
| 2025-11-13 | 2025-11-13 | Quarterly Result Announcement | NA | 1.82% |
Galaxy Medicare Competitors Screener - Peer Stocks Comparison
Screen GML competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.
The comparison table covers 10 companies in the Healthcare sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Poly Medicure | 16,966 | 53.16 | 1,995 | 13.43% | 321 | 43.96 |
| Tarsons Products | 1,704 | 157.94 | 447 | 9.38% | 14 | 46.87 |
| Q-Line Biotech | 1,589 | 28.16 | 342 | 5.93% | 56 | 58.40 |
| Laxmi Dental | 1,053 | 34.19 | 286 | 18.15% | 26 | 39.11 |
| Hemant Surgical Industries | 887 | 47.76 | 238 | 112.99% | 18 | 73.48 |
| Vasa Denticity | 805 | 66.80 | 283 | 12.77% | 10 | 71.29 |
| Osel Devices | 682 | 23.64 | 295 | 57.88% | 29 | 50.28 |
| Fabtech Technologies | 645 | 13.46 | 411 | 22.29% | 36 | 43.52 |
| Prevest Denpro | 456 | 21.27 | 77 | 14.31% | 21 | 46.70 |
| QMS Medical Allied Services | 398 | 33.30 | 174 | 10.27% | 12 | 73.50 |
Galaxy Medicare Company Announcements - News & Reports Screener
Screen GML latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.
Frequently Asked Questions
How is the company valued right now?
The P/B ratio is 0.77. Market capitalisation stands at ₹26.78 Cr and the dividend yield is 4.00%. The company operates in the Healthcare sector, in the Medical Equipment industry, so compare these ratios with its sector peers in the table above.
About This Data
Key statistics were last updated on October 6, 2026. This page covers 6 balance sheet periods, 7 income statement periods, 6 cash flow years and 3 shareholding periods. Information is provided for research and is not investment advice.